mucos
immun
system
respons
mediat
symbiot
relationship
host
endogen
microorgan
commens
bacteria
function
first
line
physic
immunolog
defenc
invad
pathogen
innat
acquir
immun
mucos
immun
system
maintain
immunolog
homeostasi
along
vast
expans
epitheli
surfac
area
rang
oral
nasal
caviti
respiratori
intestin
genitourinari
tract
initi
antigenspecif
immun
respons
occur
special
gateway
compris
microfold
cell
locat
epithelium
overli
follicl
mucosaassoci
lymphoid
tissu
malt
contain
immunocompet
cell
requir
gener
immun
respons
cell
b
cell
antigenpres
cell
peyer
patch
gut
nasopharynxassoci
lymphoid
tissu
nalt
two
main
compon
malt
import
induct
tissu
gener
mucos
immun
ingest
inhal
antigen
intestin
respiratori
tract
respect
fig
common
mucos
immun
system
cmi
connect
induct
site
peyer
patch
nalt
effector
site
lamina
propria
intestin
respiratori
tract
glandular
tissu
gener
antigenspecif
helper
h
celldepend
iga
respons
h
cytotox
lymphocyt
ctl
depend
immun
respons
function
first
line
defenc
mucos
surfac
review
discuss
three
issu
concern
biolog
nalt
immun
system
first
focu
uniqu
characterist
tissu
genesi
compar
peyer
patch
second
examin
immunolog
function
nalt
third
discuss
manipul
nalt
immun
system
develop
mucos
vaccin
despit
function
similar
nalt
peyer
patch
term
role
mucos
induct
site
programm
lymphoid
organogenesi
distinct
basi
recent
studi
uniqu
characterist
nalt
develop
compar
peyer
patch
becom
clear
term
kinet
cytokin
requir
chronolog
develop
normal
mice
nalt
bellshap
tissu
character
accumul
lymphoid
cell
contrast
high
endotheli
venul
hev
peyer
patch
express
mucos
vascular
addressin
celladhes
molecul
ref
naltassoci
hev
express
peripheralnod
addressin
pnad
vascular
celladhes
molecul
naltversu
peyerspatchmedi
mucos
immun
abstract
recent
studi
indic
mechan
nasopharynxassoci
lymphoid
tissu
nalt
organogenesi
differ
lymphoid
tissu
nalt
import
role
induct
mucos
immun
respons
includ
gener
helper
helper
cell
igacommit
b
cell
moreov
intranas
immun
lead
induct
antigenspecif
protect
immun
mucos
system
immun
compart
therefor
greater
understand
differ
nalt
organ
lymphoid
tissu
peyer
patch
facilit
develop
nasal
vaccin
special
antigensampl
cell
locat
follicleassoci
epithelium
organ
mucosaassoci
lymphoid
tissu
cell
deliv
antigen
transepitheli
vesicular
transport
aerodigest
lumen
directli
subepitheli
lymphoid
tissu
nasopharynxassoci
lymphoid
tissu
peyer
patch
fig
rat
develop
nalt
also
observ
postnat
small
accumul
lymphoid
cell
find
indic
prenat
initi
lymphoid
organogenesi
peyer
patch
postnat
initi
nalt
intrigu
possibl
naltgenesi
programm
trigger
birth
stimulatori
signal
provid
environment
antigen
mitogen
view
support
find
nasal
administr
cholera
toxin
wellknown
mucos
immunogen
adjuv
activ
result
acceler
nalt
organogenesi
develop
bellshap
lymphoid
tissu
therefor
environment
stimul
might
essenti
nalt
organogenesi
although
shown
associ
tissu
genesi
peyer
patch
cluster
stromal
cell
occur
site
peyerspatch
develop
day
coitu
determin
nalt
develop
use
immunohistochemistri
analys
pnad
express
wildtyp
mice
variou
age
nalt
format
observ
embryogenesi
newborn
mice
fig
wherea
peyer
patch
alreadi
present
embryo
domeshap
lymphoid
tissu
instead
pnad
hev
associ
lymphocyt
first
detect
bilater
nasal
tissu
week
birth
complet
format
bellshap
nalt
includ
lymphoid
cell
observ
week
birth
common
mucos
immun
system
cmi
integr
pathway
allow
commun
organ
mucosaassoci
lymphoid
tissu
induct
site
diffus
mucos
tissu
effector
site
enabl
induct
regul
hostprotect
immun
pathogen
microorgan
blood
circul
figur
common
mucos
immun
system
lumin
antigen
transport
nasopharynxassoci
lymphoid
tissu
nalt
peyer
patch
microfold
cell
present
epithelium
overli
nalt
peyerspatch
follicl
dendrit
cell
process
present
antigen
cell
lymphoid
tissu
cell
stimul
dendrit
cell
preferenti
induc
igacommit
bcell
develop
germin
centr
lymphoid
follicl
iga
class
switch
affin
matur
b
cell
rapidli
migrat
nalt
peyer
patch
region
cervic
lymph
node
mesenter
lymph
node
respect
effer
lymphat
final
antigenspecif
cell
iga
b
cell
migrat
effector
site
nasal
passag
intestin
lamina
propria
thorac
duct
blood
circul
iga
b
cell
plasmablast
differenti
igaproduc
plasma
cell
presenc
cytokin
produc
helper
h
cell
subsequ
produc
dimer
polymer
form
iga
dimer
form
iga
becom
secretori
iga
bind
polymer
ig
receptor
becom
secretori
compon
process
secretori
iga
format
display
monolay
epitheli
cell
line
mucosa
secretori
iga
releas
nasal
passag
intestin
tract
tcr
tcell
receptor
tnf
correspond
receptor
receptor
tnf
receptor
creat
condit
program
inflamm
control
secondari
lymphoidtissu
genesi
tabl
lt
essenti
secondari
lymphoidtissu
organogenesi
associ
mucos
immun
system
delet
either
gene
encod
lt
lt
receptor
artifici
blockad
interact
cytokin
receptor
embryon
period
result
inhibit
peyerspatch
peripher
lymphnod
develop
exampl
delet
gene
prevent
peyerspatch
format
greatli
limit
number
lymph
node
develop
form
heterotrim
transduc
activ
signal
contribut
organ
secondari
lymphoid
tissu
fusion
protein
infus
antagon
biolog
function
heterotrim
lymphoid
tissu
form
differ
anatom
locat
depend
embryon
stage
perturb
introduct
fusion
protein
find
show
time
secondari
lymphoidtissu
develop
regul
embryogenesi
also
found
infus
embryon
day
e
suppress
peyerspatch
develop
effect
format
lymph
node
studi
clearli
indic
import
program
inflamm
mediat
genesi
peyer
patch
tabl
fig
also
known
anoth
membranebound
member
tnf
famili
light
bind
howev
lymph
node
peyer
patch
develop
absenc
light
find
indic
interact
essenti
compon
program
inflamm
initi
peyerspatch
genesi
particular
time
gestat
period
addit
cytokin
associ
mucos
immun
system
name
also
crucial
role
initi
peyerspatch
genesi
produc
mous
human
intestin
epitheli
cell
provid
stimul
growth
signal
neighbour
intestin
intraepitheli
cell
mice
defici
receptor
format
peyer
patch
lymph
node
impair
similarli
function
block
administr
singl
inject
antagonist
monoclon
antibodi
pregnant
mother
result
offspr
defici
peyer
patch
show
normal
lymphnod
develop
find
emphas
tissuegenesi
programm
crucial
initi
peyerspatch
format
appropri
stage
embryogenesi
recent
model
describ
develop
peyer
patch
propos
basi
evid
shown
lymphoidlineag
observ
format
nalt
adult
mice
born
rais
germfre
condit
hk
sf
unpublish
observ
nonetheless
strong
possibl
initi
nalt
genesi
program
activ
birth
subsequ
matur
process
control
environment
antigen
show
cytokinemedi
nalt
organogenesi
uniqu
import
summar
mechan
peyerspatch
lymphnod
organogenesi
compar
purpos
wwwnaturecomreviewsimmunol
r
e
v
e
w
peyerspatch
format
requir
cytokinesignal
cascad
involv
tabl
fig
examin
whether
ident
receptorsignal
cascad
would
trigger
nalt
develop
format
nalt
studi
mice
lack
peyer
patch
andor
lymph
node
includ
alyali
mice
mice
treat
utero
fusion
protein
tabl
nasal
lymphoid
tissu
detect
mous
strain
lack
peyer
patch
peyer
patch
lymph
node
defici
proinflammatori
cytokin
cascad
separ
studi
harmsen
colleagu
confirm
format
nalt
absenc
signal
author
also
show
nalt
format
reconstitut
mice
defici
tnf
adopt
transfer
wildtyp
bone
marrow
even
though
peyer
patch
develop
mice
find
support
idea
nalt
develop
conform
model
program
inflamm
requir
genesi
peyer
patch
fig
peyerspatch
format
also
shown
requir
signal
pathway
addit
cascad
nalt
develop
examin
mice
nalt
peyer
patch
found
develop
mice
taken
togeth
find
directli
show
nalt
format
independ
tissu
genesi
fig
uniqu
subset
mononuclear
cell
character
shown
function
induc
cell
organogenesi
secondari
lymphoid
tissu
includ
peyer
patch
high
frequenc
cell
observ
intestin
tract
embryon
stage
develop
fig
furthermor
identifi
one
cell
consid
peyerspatch
induc
express
cxcchemokin
receptor
produc
membraneassoci
heterotrim
wherea
mesenchymallineag
intercellular
adhes
molecul
peyerspatch
organ
express
fig
follow
stimulatori
signal
provid
peyerspatch
induc
express
activ
peyerspatch
organ
turn
peyerspatch
organ
produc
chemokin
cxcchemokin
ligand
ccchemokin
ligand
stimul
peyerspatch
induc
ccchemokin
receptor
ref
reciproc
interact
induc
organ
cell
chemokin
cytokin
receptor
essenti
format
peyer
patch
fig
loss
compon
either
signal
programm
suffici
disrupt
secondari
lymphoidtissu
develop
indic
loss
peyer
patch
mice
furthermor
delet
gene
encod
partial
reduc
format
number
peyer
patch
tabl
lack
peyer
patch
lymph
node
alymphoplasia
alyali
mice
defect
nik
nuclear
induc
kinas
function
also
fit
model
recent
analys
establish
nik
essenti
transduct
signal
tnfr
famili
includ
alyali
mice
lack
peyer
patch
nik
mutat
inhibit
reciproc
interact
peyerspatch
induc
organ
mediat
evid
support
model
come
studi
show
mice
lack
induc
cell
owe
genet
delet
transcript
regul
inhibitor
dna
bind
retinoicacidreceptorrel
orphan
also
lack
peyer
patch
lymph
node
cell
cell
express
heterodim
consist
tcell
receptor
present
mainli
intestin
epithelium
intraepitheli
lymphocyt
iel
although
exact
function
cell
iel
still
unknown
suggest
mucos
cell
involv
innat
immun
respons
mucos
immun
system
cell
express
receptor
differenti
fetal
liver
cell
induc
peyerspatch
format
embryon
stage
stromal
cell
present
anlagen
peyer
patch
also
express
vascular
celladhes
molecul
intercellular
adhes
molecul
peyerspatch
develop
initi
cooper
peyerspatch
induc
disorgan
cln
mln
nd
alyali
alymphoplasia
mous
cln
cervic
lymph
node
cxcchemokin
ligand
cxcchemokin
receptor
receptor
inhibitor
dna
bind
receptor
lt
lymphotoxin
receptor
fusion
protein
mln
mesenter
lymph
node
nalt
nasopharynxassoci
lymphoid
tissu
nd
determin
nik
kinas
retinoicacidreceptorrel
orphan
tranc
tumournecrosisfactorrel
activationinduc
cytokin
develop
report
mice
might
indic
although
nalt
peyer
patch
induc
cell
phenotyp
induc
cell
classifi
two
distinct
group
basi
depend
fig
think
popul
induc
cell
essenti
peyerspatch
tissu
genesi
regul
wherea
subset
induc
cell
lack
express
requir
nalt
genesi
regul
fig
although
proven
experiment
two
inducercel
popul
nalt
peyerspatch
organogenesi
might
determin
program
level
transcript
regul
fig
addit
also
possibl
popul
induc
cell
absent
mice
mice
instead
anoth
asyetundefin
cell
popul
substitut
classic
induc
cell
format
nalt
present
mice
mice
studi
requir
investig
possibl
other
gene
respons
induct
induc
cell
surprisingli
delet
gene
complet
impair
genesi
secondari
lymphoid
tissu
includ
nalt
peyer
patch
induc
cell
shown
accumul
site
nalt
format
birth
fig
therebi
clarifi
role
cell
induct
nalt
develop
directli
show
cell
respons
genesi
nalt
fetal
liver
cell
adopt
transfer
wildtyp
mice
newborn
mice
seven
day
transfer
cell
observ
migrat
site
nalt
format
week
transfer
naltlik
structur
detect
find
first
show
directli
vivo
induc
cell
essenti
initi
organogenesi
secondari
lymphoid
tissu
nalt
transcript
regul
also
shown
requir
develop
induc
cell
delet
gene
encod
suppress
peyerspatch
lymphnod
organogenesi
ltand
nikindepend
pathway
wwwnaturecomreviewsimmunol
r
e
v
e
w
positiveand
negativeregulatori
signal
induct
antigenspecif
immun
toler
respect
cellular
molecular
contribut
immunocompet
cell
present
nalt
gener
toler
mucos
expos
antigen
unknown
littl
known
induct
nasal
induc
toler
focu
role
nalt
induct
protect
immun
germinalcentr
region
contain
high
frequenc
igm
b
cell
express
activationinduc
cytidin
deaminas
aid
essenti
convers
earli
studi
shown
incub
igm
iga
b
cell
isol
peyer
patch
presenc
cytokin
transform
growth
result
gener
igm
iga
b
cell
postswitch
igacommit
b
cell
migrat
mucos
effector
tissu
intestin
lamina
propria
process
mediat
group
home
chemokin
receptor
ligand
integrin
interact
discuss
later
intestin
lamina
propria
cell
becam
iga
plasma
cell
presenc
igaenhanc
cytokin
ref
gener
accept
organ
lymphoid
structur
malt
peyer
patch
function
induct
site
gener
igacommit
b
cell
csr
wherea
diffus
tissu
intestin
lamina
propria
function
effector
site
product
iga
fig
howev
find
iga
class
switch
occur
intestin
lamina
propria
without
involv
rodent
nalt
found
side
nasopharyng
duct
dorsal
cartilagin
soft
palat
consid
analog
waldey
ring
human
also
recent
studi
naltlik
structur
lymphocyt
aggreg
form
follicl
identifi
human
nasal
mucosa
particularli
middl
concha
children
less
two
year
age
indic
equival
mous
nalt
develop
human
nalt
consist
follicleassoci
epithelium
fae
hev
tcelland
bcellenrich
area
antigensampl
cell
present
epithelium
nalt
special
antigen
uptak
similar
fae
peyer
patch
antigenpres
cell
includ
dendrit
cell
dc
macrophag
also
found
nalt
nalt
contain
lymphoid
cell
requir
induct
regul
mucos
immun
respons
antigen
deliv
nasal
caviti
exampl
intranas
administr
reoviru
result
format
germin
centr
nalt
lead
clonal
expans
antigeninduc
iga
b
cell
subsequ
gener
reovirusspecif
iga
respiratori
intestin
tract
moreov
reovirusspecif
ctl
also
induc
nalt
high
frequenc
find
show
nalt
potent
induct
site
mucos
immun
system
addit
induct
posit
immun
respons
nasal
deposit
antigen
shown
effect
induct
system
unresponsivenessa
form
mucos
induc
toler
propos
retinoicacidreceptorrel
orphan
inhibitor
dna
bind
essenti
gener
receptor
express
cell
induct
peyerspatch
organogenesi
contrast
gener
induc
cell
involv
nasopharynxassoci
lymphoid
tissu
nalt
organogenesi
regul
howev
model
remain
test
experiment
possibl
exist
see
main
text
nalt
genesi
mice
initi
adopt
transfer
cell
wildtyp
mice
matur
nalt
format
incomplet
indic
cell
popul
endogen
express
site
nalt
might
requir
full
matur
nalt
igm
b
cell
precondit
undergo
iga
class
switch
select
locat
organ
mucosaassoci
induct
tissu
nalt
peyer
patch
find
confirm
molecular
analysi
iga
csrassoci
mrna
specif
aid
circular
transcript
transcript
express
aid
circular
transcript
upregul
preferenti
convers
quickli
downregul
molecular
event
consid
hallmark
b
cell
undergo
iga
class
switch
express
transcript
indic
complet
igaspecif
csr
analysi
show
express
aid
circular
transcriptand
transcriptspecif
mrna
restrict
organ
mucos
induct
tissu
nalt
peyer
patch
found
diffus
effector
tissu
nasal
passag
intestin
lamina
propria
furthermor
organ
mucos
lymphoid
tissu
known
associ
cell
find
indic
iga
class
switch
least
cell
requir
organ
lymphoid
structur
nalt
peyer
patch
aerodigest
tract
nalt
also
recent
shown
import
site
gener
memori
b
cell
produc
highaffin
iga
taken
togeth
find
show
nalt
contain
immunocompet
cell
requir
induct
regul
antigenspecif
h
h
respons
bcell
immun
respons
nalt
peyer
patch
thought
similar
immunolog
characterist
biolog
function
well
contain
type
resid
immunocompet
cell
similar
oral
immun
nasal
immun
stimul
antigenspecif
h
h
respons
iga
respons
distant
mucos
effector
tissu
howev
gener
nalttarget
immun
effect
induc
antigenspecif
immun
respiratori
reproduct
tissu
wherea
peyerspatchtarget
immun
promot
gener
protect
immun
gastrointestinaltract
tissu
support
compartment
cmi
provid
recent
shown
nasal
immun
induc
express
high
level
integrin
igacommit
b
cell
allow
effici
traffic
respiratori
genitourinari
tract
express
correspond
ligand
ref
contrast
oral
induc
igacommit
b
cell
express
well
integrin
migrat
site
small
intestin
express
andor
togeth
andor
ref
despit
nalt
peyer
patch
belong
mucos
immun
system
subtl
differ
discuss
indic
tissu
genesi
biolog
function
nalt
peyer
patch
might
differ
anatom
peyer
patch
cast
assumpt
doubt
stromalcellderiv
present
intestin
lamina
propria
shown
trigger
igm
cell
switch
iga
b
cell
mice
defici
programmedinflammationassoci
cytokin
form
peyer
patch
level
iga
respons
reduc
compar
wildtyp
mice
howev
reconstitut
mice
ltexpress
bonemarrow
cell
transplant
intestin
segment
recombinationactiv
gene
rag
mice
mice
result
recoveri
iga
respons
find
impli
least
igacommit
b
cell
develop
even
absenc
peyer
patch
mice
also
shown
capabl
induc
antigenspecif
iga
respons
oral
administ
salmonella
typhimurium
despit
absenc
organ
lymphoid
tissu
associ
mucos
compart
although
find
provid
support
evid
environ
diffus
lamina
propria
region
selfsuffici
csr
lead
gener
igacommit
b
cell
also
possibl
unidentifi
programmedinflammationindepend
miniatur
lymphoid
aggreg
recent
character
isol
lymphoid
follicl
role
mount
iga
respons
case
peyerspatch
defici
find
igaspecif
csr
occur
diffus
mucos
effector
tissu
indic
organ
mucos
tissu
essenti
gener
igacommit
b
cell
digest
tract
although
new
view
still
controversi
shown
intestin
iga
produc
two
group
cell
cell
cell
interest
possibl
igaspecif
csr
cell
requir
organ
lymphoid
structur
wherea
structur
essenti
igaisotyp
switch
cell
support
view
shown
b
cell
gutassoci
lymphoid
tissu
cell
wherea
cell
locat
preferenti
intestin
laminapropria
region
think
initi
antigen
stimul
trigger
igaisotyp
switch
cell
might
provid
antigen
sampl
cell
locat
dome
epithelium
fae
peyer
patch
contrast
igaspecif
csr
process
occur
cell
might
trigger
antigen
sampl
newli
identifi
villou
cell
locat
adjac
laminapropria
region
contain
observ
lymphoidlik
structur
nalt
similar
import
initi
iga
bcell
respons
peyer
patch
investig
whether
igaisotyp
switch
also
occur
diffus
tissu
nasal
passag
igm
b
cell
prerequisit
csr
found
organ
induct
site
nalt
mostli
absent
diffus
effector
tissu
nasal
passag
respiratori
mucos
immun
system
similarli
igm
b
cell
observ
organ
peyer
patch
intestin
tract
intestin
lamina
propria
studi
follicular
dc
fdc
cell
dendrit
morpholog
present
lymph
node
cell
display
surfac
intact
antigen
held
immun
complex
b
cell
present
lymph
node
interact
antigen
fdc
nonhaematopoiet
origin
relat
dendrit
cell
igm
low
igd
hi
hi
cell
origin
bone
marrow
distribut
mucos
system
immun
compart
continu
secret
antibodi
high
affin
fine
specif
circular
transcript
circular
dna
molecul
present
activ
b
cell
consist
interven
gene
hallmark
b
cell
process
iga
class
switch
germlin
transcript
detect
igacommit
b
cell
class
switch
wwwnaturecomreviewsimmunol
r
e
v
e
w
guid
antigen
mucos
epithelium
sendai
viru
use
fusion
protein
invas
respiratori
epitheli
cell
novel
hybrid
antigendeliveri
vehicl
also
devis
use
envelop
fusion
glycoprotein
sendai
viru
use
haemagglutin
viru
japan
hvj
fusion
protein
display
surfac
liposom
either
fusogen
liposom
hvj
liposom
contain
antigen
interest
deliveri
vehicl
use
intranas
administ
antigen
conjug
greenfluoresc
protein
success
reach
antigensampl
cell
locat
epithelium
nalt
fusogen
liposom
also
found
effect
deliv
antigen
epitheli
cell
macrophag
nalt
nasal
passag
furthermor
shown
intranas
administ
hvj
liposom
contain
hiv
glycoprotein
antigen
also
known
env
power
tool
induc
serum
igg
mucos
iga
also
detect
nasal
wash
saliva
faecal
extract
vagin
wash
tabl
find
show
novel
hybrid
antigendeliveri
vehicl
fusogen
liposom
hvj
liposom
effect
transport
vaccin
antigen
nalt
initi
antigenspecif
iga
respons
distant
mucos
effector
site
furthermor
immun
method
also
induc
antigenspecif
immun
respons
product
igg
system
compart
tabl
antigensampl
cell
scatter
throughout
nalt
epithelium
seem
logic
develop
mcelltarget
nasal
vaccin
one
promis
approach
use
molecul
involv
normal
cours
invas
infecti
agent
reoviru
enter
pathogen
known
invad
host
cell
locat
epithelium
peyer
patch
viral
haemagglutinin
protein
reoviru
crucial
role
attach
entri
cell
viru
shown
recogn
mous
cell
present
airway
recombin
form
protein
bind
cell
associ
nalt
epithelium
basi
find
attempt
made
develop
mcelltarget
dna
vaccin
use
protein
guid
molecul
conjug
eukaryot
express
vector
encod
luciferas
known
pcmvluc
administ
intranas
protein
specif
bind
apic
surfac
cell
situat
follicular
epithelium
environment
distinct
locat
target
cmi
would
therefor
seem
logic
choic
develop
second
gener
mucos
nasal
oral
vaccin
induc
antigenspecif
immun
responsessuch
combin
h
h
respons
ctl
respons
iga
igg
respons
common
andor
select
region
mucos
compart
well
system
site
use
naltand
peyerspatchiniti
mucos
immun
respons
fig
describ
nalt
one
key
compon
organ
lymphoid
tissu
contain
immunocompet
cell
requir
induct
antigenspecif
immun
respons
therefor
like
central
role
develop
nasal
vaccin
nasal
vaccin
proven
effect
regimen
stimul
respiratori
immun
system
furthermor
rout
mucos
immun
elicit
humor
cellmedi
antigenspecif
immun
respons
anoth
attract
featur
nasal
immun
requir
much
smaller
dose
antigen
oral
vaccin
induct
antigenspecif
mucos
system
immun
respons
antigen
expos
degrad
digest
enzym
intranas
administr
vaccin
antigen
alon
fail
fulli
stimul
nalt
research
attempt
develop
effect
nalttarget
vaccineantigen
deliveri
system
develop
safe
effect
immuneenhanc
molecul
adjuv
intranas
administr
vaccin
antigen
antigen
known
immunogen
particul
form
solubl
form
vulner
antigendegrad
enzym
acid
associ
mucos
environ
overcom
obstacl
much
effort
focus
creation
novel
nontox
nonimmunogen
vaccin
vehicl
effect
deliv
even
solubl
form
antigen
organ
mucos
induct
tissu
vehicl
need
protect
vaccin
compon
degrad
enhanc
uptak
mucos
surfac
perhap
function
adjuv
among
variou
candid
mucos
antigen
deliveri
sendaivirusassoci
fusion
protein
seem
particularli
suit
function
molecul
cholera
toxin
nct
heatlabil
enterotoxin
nlt
caus
sever
diarrhoea
unsuit
use
human
overcom
hurdl
research
substitut
singl
amino
acid
gener
nontox
mutant
form
cholera
toxin
mct
heatlabil
enterotoxin
mlt
retain
adjuvant
nativ
form
induc
ribosyl
adp
associ
toxic
activ
effort
devis
safe
first
gener
toxinbas
adjuv
focus
mct
phenylalanin
replac
serin
posit
mct
lysin
replac
glutam
acid
posit
mutat
creat
make
singl
aminoacid
substitut
activ
centr
adpribosyltransferas
subunit
cholera
toxin
two
mutant
form
cholera
toxin
shown
safe
vitro
analys
adpribosyl
activ
cyclic
amp
format
well
vivo
examin
diarrhoealik
symptom
pneumococc
surfaceprotein
pspa
new
candid
vaccin
antigen
prevent
infect
streptococcu
pneumoniaewa
intranas
administ
mct
antigenspecif
mucos
iga
system
igg
respons
elicit
mice
intranas
immun
pspa
mct
also
protect
lethal
challeng
pneumonia
interestingli
tetanustoxoid
vaccin
current
administ
inject
intranas
administ
one
two
mct
gener
protect
immun
challeng
toxin
independ
studi
also
shown
mct
safest
effect
current
avail
toxinbas
mutant
adjuv
taken
togeth
find
support
idea
mct
strong
candid
effect
mucos
adjuv
gener
protect
immun
nasal
rout
administr
inde
find
indic
current
prefer
injectiontyp
vaccin
reconsid
futur
greater
use
made
spraytyp
vaccin
includ
mct
safe
toxinbas
adjuv
box
enhanc
efficaci
mct
mucos
adjuv
secondgener
chimerictyp
adjuv
construct
subunit
mct
mcta
b
subunit
nlt
nltb
therefor
adjuv
immunobiolog
properti
cholera
toxin
heatlabil
enterotoxin
nasal
immun
influenzaviru
haemagglutinin
plu
newli
creat
chimer
mucos
adjuv
mctanltb
result
signific
haemagglutininspecif
serum
igg
iga
respons
tabl
addit
mice
intranas
immun
haemagglutinin
mctanltb
show
high
level
haemagglutininspecif
iga
nasal
lung
wash
protect
viral
challeng
find
show
nasal
vaccin
contain
mct
mctanltb
effect
induct
protect
immun
goal
mucosalvaccin
develop
realiz
without
creation
novel
safe
mucos
adjuv
nalt
lead
gener
luciferasespecif
serum
igg
mucos
iga
respons
nasal
vaccin
assembl
use
protein
result
ctl
respons
variou
mucosaassoci
system
immun
compart
includ
reproduct
tissu
spleen
respect
find
emphas
efficaci
nalttarget
immun
induct
humor
andor
cellmedi
antigenspecif
immun
respons
mucos
system
immun
compart
infrequ
caus
seriou
complic
bcg
commonli
use
vaccin
control
tuberculosi
consid
lowrisk
vaccin
recombin
form
bcg
use
vaccineantigen
deliveri
vehicl
strong
adjuv
activ
induc
humor
cellmedi
immun
respons
inde
system
administr
rbcg
express
hiv
antigen
shown
effect
induc
cellmedi
immun
studi
shown
intrans
administr
rbcg
express
neutral
epitop
hiv
induc
igg
neutral
activ
year
normal
immunodefici
mice
tabl
furthermor
serum
igg
also
shown
effect
neutral
homolog
strain
hiv
accordingli
rbcg
show
promis
effect
nasalimmun
vehicl
induct
prolong
antigenspecif
antibodi
respons
cholera
toxin
produc
vibrio
cholera
heatlabil
enterotoxin
escherichia
coli
function
adjuv
enhanc
mucos
serum
antibodi
respons
coadminist
protein
antigen
deliv
oral
nasal
rout
unfortun
despit
efficaci
mucos
adjuv
nativ
form
effect
rout
elicit
optim
protect
immun
mucos
system
immun
compart
effect
induc
antigenspecif
immun
reproduct
tract
well
upper
respiratori
tract
gener
crossprotect
immun
gut
common
mucos
immun
system
avoid
degrad
vaccin
antigen
caus
digest
enzym
requir
smaller
dose
antigen
oral
immun
requir
inject
less
pain
requir
train
medic
personnel
deliveri
possibl
deposit
antigen
central
nervou
system
olfactori
bulb
olfactori
nerv
requir
investig
requir
adjuv
safeti
clinic
determin
clinic
studi
indic
bell
palsi
caus
influenza
nasal
vaccin
contain
nativ
form
escherichia
coli
heatlabil
enterotoxin
mucos
adjuv
wwwnaturecomreviewsimmunol
r
e
v
e
w
protein
sar
coronaviru
abl
induc
protect
immun
african
green
monkey
includ
sarscoronavirusspecif
neutral
antibodi
although
experi
essenti
find
appli
develop
vaccin
sar
use
human
studi
emphas
use
mucos
immun
immunoprophylaxi
infecti
diseas
mucos
immun
system
recogn
import
first
line
defenc
invad
pathogen
nalt
peyer
patch
import
induct
site
initi
antigenspecif
mucos
iga
serum
igg
respons
well
ctl
immun
respons
mucos
system
site
way
nalt
peyer
patch
function
maxim
twotier
immunolog
barrier
host
respiratori
mucos
immun
system
sever
immunolog
characterist
distinct
peyerspatchcentr
intestin
mucos
immun
system
although
tissuegenesi
programm
secondari
lymphoid
tissu
includ
peyer
patch
begin
embryon
life
naltorganogenesi
programm
initi
birth
lymphoid
organogenesi
peyer
patch
requir
cytokinemedi
program
inflamm
signal
wherea
initi
nalt
develop
seem
independ
although
induc
cell
nalt
peyer
patch
common
phenotyp
naltinduc
cell
seem
regul
alon
wherea
peyerspatchinduc
cell
depend
organogenesi
programm
nalt
differ
secondari
lymphoid
tissu
peyer
patch
effort
aim
elucid
distinct
molecular
characterist
naltgenesi
programm
function
consequ
clearli
import
thorough
understand
uniqu
molecular
cellular
properti
naltcentr
mucos
immun
system
develop
success
nasal
vaccin
late
earli
efficaci
immun
intranas
administ
vaccin
infect
influenza
viru
shown
larg
clinic
trial
osaka
japan
nasalspray
vaccin
contain
live
attenu
influenza
viru
administ
volunt
recent
year
two
type
intranas
administ
influenza
vaccin
inactiv
form
live
attenu
form
introduc
switzerland
unit
state
respect
inde
earli
inactiv
form
nasal
vaccin
contain
small
amount
nlt
mucos
adjuv
introduc
switzerland
howev
influenza
vaccin
withdrawn
market
develop
bell
palsi
recipi
nasal
vaccin
causal
relationship
intranas
administ
inactivatedinfluenza
vaccin
use
switzerland
incid
bell
palsi
formal
establish
recent
casecontrol
studi
stage
caus
pathogenesi
bell
palsi
remain
unclear
howev
nlt
shown
proinflammatori
properti
possibl
neurolog
toxic
coformul
nlt
present
inactivatedinfluenza
vaccin
suspect
caus
agent
find
highlight
develop
safe
mucos
adjuv
crucial
progress
made
toward
safe
effect
mucos
vaccin
past
year
basi
promis
clinic
trial
show
induct
protect
immun
intranas
administ
coldadapt
influenza
vaccin
known
flumist
made
avail
healthi
american
age
ref
note
concept
coldadapt
influenza
viru
report
ref
year
requir
discoveri
translat
intrans
vaccin
infect
influenza
viru
recent
concept
nasal
immun
adopt
develop
vaccin
sever
acut
respiratori
syndrom
sar
experiment
nasal
administ
vaccin
sar
consist
recombin
attenu
parainfluenza
viru
express
envelop
spike
bell
palsi
facial
paralysi
thought
trigger
viral
infect
facial
nerv
oedemat
patient
suffer
diseas
